SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-02-006012
Filing Date
2002-06-07
Accepted
2002-06-07 17:19:50
Documents
7
Period of Report
2002-03-31

Document Format Files

Seq Description Document Type Size
1 K-V PHARMACEUTICAL COMPANY c70076e10vk.txt 10-K 232414
3 FIFTH AMENDMENT TO LOAN AGREEMENT c70076exv4wl.txt EX-4.L 30373
4 STOCK OPTION AGREEMENT c70076exv10wii.txt EX-10.II 15585
5 STOCK OPTION AGREEMENT c70076exv10wjj.txt EX-10.JJ 8767
6 STOCK OPTION AGREEMENT c70076exv10wkk.txt EX-10.KK 8755
7 LIST OF SUBSIDIARIES c70076exv21.txt EX-21 366
8 CONSENT OF BDO SEIDMAN, LLP c70076exv23.txt EX-23 722
  Complete submission text file 0000950123-02-006012.txt   299236
Mailing Address 2503 S HANLEY RD ST LOUIS MO 63144
Business Address 2503 S HANLEY RD ST LOUIS MO 63144 3146456600
KV PHARMACEUTICAL CO /DE/ (Filer) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-09601 | Film No.: 02674156
SIC: 2834 Pharmaceutical Preparations